Stefanie Morris
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 12
- Lung Cancer Research Studies 4
- Cancer Immunotherapy and Biomarkers 4
- HER2/EGFR in Cancer Research 2
- CAR-T cell therapy research 1
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Tony S.K. Mok (2 shared papers)Federico Cappuzzo (2 shared papers)David S. Shames (1 shared paper)Mark L. McCleland (1 shared paper)Robert M. Jotte (1 shared paper)Eugene Kim (1 shared paper)Meghna Das Thakur (1 shared paper)Makoto Nishio (1 shared paper)
- Journals
- Lung Cancer (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Journal of Thoracic Oncology (2 papers)Cancer Cell (1 paper)Cancer Cytopathology (1 paper)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Stefanie Morris
16 papers receiving 544 citations
Stefanie Morris's Hit Papers
Peers
Comparison fields: 5 of 53
- Oncology 354
- Cancer Research 62
- Pulmonary and Respiratory Medicine 121
- Epidemiology 74
- Immunology 33
Countries citing papers authored by Stefanie Morris
This map shows the geographic impact of Stefanie Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Morris more than expected).
Fields of papers citing papers by Stefanie Morris
This network shows the impact of papers produced by Stefanie Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Morris. The network helps show where Stefanie Morris may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefanie Morris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 117 | |
| 2 | 2023 | 109 | |
| 3 | Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade Hit paper breakdown → | 2024 | 105 |
| 4 | 2024 | 49 | |
| 5 | 2016 | 34 | |
| 6 | 2023 | 32 | |
| 7 | 2022 | 24 | |
| 8 | 2019 | 20 | |
| 9 | 2021 | 19 | |
| 10 | 2020 | 14 | |
| 11 | 2020 | 13 | |
| 12 | 2024 | 13 | |
| 13 | 2025 | 1 | |
| 14 | 2025 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2026 | 1 | |
| 17 | 2022 | 0 |
About Stefanie Morris
Stefanie Morris is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Cancer Research and Clinical Psychology, having authored 17 papers that have together received 553 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), HER2/EGFR in Cancer Research (2 papers), Migration, Health and Trauma (1 paper), Male Breast Health Studies (1 paper), Migration, Refugees, and Integration (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (354 citations), Cancer Research (62 citations), Pulmonary and Respiratory Medicine (121 citations), Epidemiology (74 citations) and Immunology (33 citations). Stefanie Morris has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Tony S.K. Mok, Federico Cappuzzo, David S. Shames, Mark L. McCleland, Robert M. Jotte, Eugene Kim, Meghna Das Thakur, Makoto Nishio, Martin Reck and Geetha Shankar. Their work appears in journals such as Lung Cancer, Journal for ImmunoTherapy of Cancer, Journal of Thoracic Oncology, Cancer Cell and Cancer Cytopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.